AAPL334.51+2.24 (+0.67%) ▲|ABBV261.68+4.56 (+1.77%) ▲|ABT102.73+0.78 (+0.77%) ▲|ACN194.40+10.50 (+5.71%) ▲|ADBE263.56+11.33 (+4.49%) ▲|AMAT426.19-30.30 (-6.64%) ▼|AMD495.42-20.71 (-4.01%) ▼|AMGN380.80+3.45 (+0.91%) ▲|AMT177.21-0.65 (-0.36%) ▼|AMZN253.96-2.82 (-1.10%) ▼|AVGO344.37-17.63 (-4.87%) ▼|AXP327.64+2.95 (+0.91%) ▲|BA209.92-0.54 (-0.25%) ▼|BAC59.40-3.30 (-5.26%) ▼|BKNG175.50+1.58 (+0.91%) ▲|BLK1,066.15-13.50 (-1.25%) ▼|BMY64.04+0.40 (+0.63%) ▲|BNY157.59-5.07 (-3.12%) ▼|BRK-B515.18+4.81 (+0.94%) ▲|C137.11-1.71 (-1.23%) ▼|CAT784.88-33.69 (-4.12%) ▼|CL88.27+1.47 (+1.69%) ▲|CMCSA24.89-0.32 (-1.25%) ▼|COF207.02-1.29 (-0.62%) ▼|COP136.34-1.01 (-0.74%) ▼|COST920.04+15.27 (+1.69%) ▲|CRM259.43+11.71 (+4.73%) ▲|CSCO110.31-1.82 (-1.62%) ▼|CVS95.76+1.10 (+1.16%) ▲|CVX211.80-2.26 (-1.06%) ▼|DE680.83+5.09 (+0.75%) ▲|DHR202.76+2.62 (+1.31%) ▲|DIS108.79+2.24 (+2.10%) ▲|DUK118.88-0.54 (-0.45%) ▼|EMR148.27-3.92 (-2.58%) ▼|FDX312.06+1.29 (+0.42%) ▲|GD357.32+1.42 (+0.40%) ▲|GE317.53-6.13 (-1.89%) ▼|GEV873.21-84.06 (-8.78%) ▼|GILD146.23+2.51 (+1.75%) ▲|GM87.09+1.47 (+1.72%) ▲|GOOG344.74+9.29 (+2.77%) ▲|GOOGL348.22+9.72 (+2.87%) ▲|GS989.32-39.86 (-3.87%) ▼|HD311.65+2.91 (+0.94%) ▲|HON201.22-1.15 (-0.57%) ▼|IBM249.31+6.02 (+2.47%) ▲|INTC97.54-5.41 (-5.25%) ▼|INTU339.28+17.71 (+5.51%) ▲|ISRG378.26+9.11 (+2.47%) ▲|JNJ267.06+1.48 (+0.56%) ▲|JPM350.09-6.14 (-1.72%) ▼|KO89.24+0.95 (+1.07%) ▲|LIN463.08-3.14 (-0.67%) ▼|LLY1,138.90+23.20 (+2.08%) ▲|LMT530.83+6.64 (+1.27%) ▲|LOW198.79+1.97 (+1.00%) ▲|LRCX274.88-23.34 (-7.83%) ▼|MA572.51+3.32 (+0.58%) ▲|MCD257.40+4.87 (+1.93%) ▲|MDLZ62.31-0.14 (-0.22%) ▼|MDT93.74+2.78 (+3.05%) ▲|META666.95+18.92 (+2.92%) ▲|MMM162.12-2.85 (-1.73%) ▼|MO70.60+1.62 (+2.34%) ▲|MRK144.64+0.71 (+0.49%) ▲|MS207.34-7.05 (-3.29%) ▼|MSFT507.36+11.73 (+2.37%) ▲|MU927.33-47.93 (-4.91%) ▼|NEE81.77-0.54 (-0.66%) ▼|NFLX80.41+3.01 (+3.89%) ▲|NKE37.05+0.25 (+0.68%) ▲|NOW142.45+9.92 (+7.48%) ▲|NVDA211.77-6.52 (-2.99%) ▼|ORCL143.52-6.77 (-4.50%) ▼|PEP136.41+0.09 (+0.07%) ▲|PFE27.74+0.02 (+0.07%) ▲|PG146.09+0.82 (+0.56%) ▲|PLTR173.86+6.63 (+3.96%) ▲|PM194.39+3.33 (+1.74%) ▲|QCOM180.40-1.57 (-0.86%) ▼|RTX195.05-2.64 (-1.33%) ▼|SBUX99.12+0.38 (+0.38%) ▲|SCHW107.25+0.00 (+0.00%) ▲|SO86.77-0.40 (-0.46%) ▼|SPG204.77-0.06 (-0.03%) ▼|T26.57+0.51 (+1.94%) ▲|TMO611.41+1.59 (+0.26%) ▲|TMUS182.41+0.08 (+0.04%) ▲|TSLA360.37-5.07 (-1.39%) ▼|TXN263.76-4.95 (-1.84%) ▼|UBER72.57+0.90 (+1.25%) ▲|UNH383.76+6.99 (+1.86%) ▲|UNP284.89+0.49 (+0.17%) ▲|UPS102.33+2.05 (+2.04%) ▲|USB62.62-0.23 (-0.36%) ▼|V374.27+3.82 (+1.03%) ▲|VZ51.33+0.72 (+1.43%) ▲|WFC88.60-1.69 (-1.87%) ▼|WMT109.53+2.38 (+2.22%) ▲|XOM164.53-1.46 (-0.88%) ▼|AAPL334.51+2.24 (+0.67%) ▲|ABBV261.68+4.56 (+1.77%) ▲|ABT102.73+0.78 (+0.77%) ▲|ACN194.40+10.50 (+5.71%) ▲|ADBE263.56+11.33 (+4.49%) ▲|AMAT426.19-30.30 (-6.64%) ▼|AMD495.42-20.71 (-4.01%) ▼|AMGN380.80+3.45 (+0.91%) ▲|AMT177.21-0.65 (-0.36%) ▼|AMZN253.96-2.82 (-1.10%) ▼|AVGO344.37-17.63 (-4.87%) ▼|AXP327.64+2.95 (+0.91%) ▲|BA209.92-0.54 (-0.25%) ▼|BAC59.40-3.30 (-5.26%) ▼|BKNG175.50+1.58 (+0.91%) ▲|BLK1,066.15-13.50 (-1.25%) ▼|BMY64.04+0.40 (+0.63%) ▲|BNY157.59-5.07 (-3.12%) ▼|BRK-B515.18+4.81 (+0.94%) ▲|C137.11-1.71 (-1.23%) ▼|CAT784.88-33.69 (-4.12%) ▼|CL88.27+1.47 (+1.69%) ▲|CMCSA24.89-0.32 (-1.25%) ▼|COF207.02-1.29 (-0.62%) ▼|COP136.34-1.01 (-0.74%) ▼|COST920.04+15.27 (+1.69%) ▲|CRM259.43+11.71 (+4.73%) ▲|CSCO110.31-1.82 (-1.62%) ▼|CVS95.76+1.10 (+1.16%) ▲|CVX211.80-2.26 (-1.06%) ▼|DE680.83+5.09 (+0.75%) ▲|DHR202.76+2.62 (+1.31%) ▲|DIS108.79+2.24 (+2.10%) ▲|DUK118.88-0.54 (-0.45%) ▼|EMR148.27-3.92 (-2.58%) ▼|FDX312.06+1.29 (+0.42%) ▲|GD357.32+1.42 (+0.40%) ▲|GE317.53-6.13 (-1.89%) ▼|GEV873.21-84.06 (-8.78%) ▼|GILD146.23+2.51 (+1.75%) ▲|GM87.09+1.47 (+1.72%) ▲|GOOG344.74+9.29 (+2.77%) ▲|GOOGL348.22+9.72 (+2.87%) ▲|GS989.32-39.86 (-3.87%) ▼|HD311.65+2.91 (+0.94%) ▲|HON201.22-1.15 (-0.57%) ▼|IBM249.31+6.02 (+2.47%) ▲|INTC97.54-5.41 (-5.25%) ▼|INTU339.28+17.71 (+5.51%) ▲|ISRG378.26+9.11 (+2.47%) ▲|JNJ267.06+1.48 (+0.56%) ▲|JPM350.09-6.14 (-1.72%) ▼|KO89.24+0.95 (+1.07%) ▲|LIN463.08-3.14 (-0.67%) ▼|LLY1,138.90+23.20 (+2.08%) ▲|LMT530.83+6.64 (+1.27%) ▲|LOW198.79+1.97 (+1.00%) ▲|LRCX274.88-23.34 (-7.83%) ▼|MA572.51+3.32 (+0.58%) ▲|MCD257.40+4.87 (+1.93%) ▲|MDLZ62.31-0.14 (-0.22%) ▼|MDT93.74+2.78 (+3.05%) ▲|META666.95+18.92 (+2.92%) ▲|MMM162.12-2.85 (-1.73%) ▼|MO70.60+1.62 (+2.34%) ▲|MRK144.64+0.71 (+0.49%) ▲|MS207.34-7.05 (-3.29%) ▼|MSFT507.36+11.73 (+2.37%) ▲|MU927.33-47.93 (-4.91%) ▼|NEE81.77-0.54 (-0.66%) ▼|NFLX80.41+3.01 (+3.89%) ▲|NKE37.05+0.25 (+0.68%) ▲|NOW142.45+9.92 (+7.48%) ▲|NVDA211.77-6.52 (-2.99%) ▼|ORCL143.52-6.77 (-4.50%) ▼|PEP136.41+0.09 (+0.07%) ▲|PFE27.74+0.02 (+0.07%) ▲|PG146.09+0.82 (+0.56%) ▲|PLTR173.86+6.63 (+3.96%) ▲|PM194.39+3.33 (+1.74%) ▲|QCOM180.40-1.57 (-0.86%) ▼|RTX195.05-2.64 (-1.33%) ▼|SBUX99.12+0.38 (+0.38%) ▲|SCHW107.25+0.00 (+0.00%) ▲|SO86.77-0.40 (-0.46%) ▼|SPG204.77-0.06 (-0.03%) ▼|T26.57+0.51 (+1.94%) ▲|TMO611.41+1.59 (+0.26%) ▲|TMUS182.41+0.08 (+0.04%) ▲|TSLA360.37-5.07 (-1.39%) ▼|TXN263.76-4.95 (-1.84%) ▼|UBER72.57+0.90 (+1.25%) ▲|UNH383.76+6.99 (+1.86%) ▲|UNP284.89+0.49 (+0.17%) ▲|UPS102.33+2.05 (+2.04%) ▲|USB62.62-0.23 (-0.36%) ▼|V374.27+3.82 (+1.03%) ▲|VZ51.33+0.72 (+1.43%) ▲|WFC88.60-1.69 (-1.87%) ▼|WMT109.53+2.38 (+2.22%) ▲|XOM164.53-1.46 (-0.88%) ▼|
23.9 C
New York
Monday, September 14, 2026

Tag: technologies

Echosens and Boehringer Ingelheim Expand Long-Standing Collaboration to Accelerate Progress in MASH Diagnosis and Care

PARIS, June 10, 2025 /PRNewswire/ -- As metabolic dysfunction-associated steatohepatitis (MASH) emerges as one of the most dangerous and underdiagnosed drivers of liver failure—affecting...

HDFC ERGO General Insurance Wins Duck Creek Standard of Excellence Customer Award at Formation ’25

HDFC ERGO General Insurance Wins Duck Creek Standard of Excellence Customer Award at Formation ’25

AirSculpt Announces Public Offering of Common Stock

MIAMI BEACH, Fla., June 09, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) (“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced the launch of an underwritten public offering of 3,160,000 shares of its common stock. The underwriter will also have a 30-day option to purchase up to 474,000 additional shares of common stock. All of the shares of common stock in the offering are being sold by the Company.

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages NAPCO Security Technologies, Inc. Investors with Losses in Excess of $100k to Secure Counsel Before Important Deadline in Securities...

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NAPCO Security Technologies, Inc. (NASDAQ: NSSC) between February 5, 2024 and February 3, 2025, both dates inclusive (the “Class Period”), of the important June 24, 2025 lead plaintiff deadline.

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Session

Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

$1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants
$1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants

Lyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive Appointments

SOUTH SAN FRANCISCO, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, today announced the appointment of Mark J. Bachleda, PharmD, MBA as an independent member of the Board of Directors, David Shook, MD as Chief Medical Officer, and Mark Meltz, JD as General Counsel and Corporate Secretary. These appointments, along with the appointment earlier in the year of Jarrad Aguirre, MD, MBA as Senior Vice President, Medical Affairs, further strengthen the Company’s clinical and commercial capabilities.

Roivant and Priovant to Host Investor Video Conference at 1:00 PM ET on Tuesday, June 17 on Brepocitinib and the Unmet Medical Need in...

BASEL, Switzerland and LONDON and NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) and Priovant Therapeutics today announced that they will host a live investor video conference at 1:00 PM ET on Tuesday, June 17 on brepocitinib, the unmet medical need for patients with dermatomyositis (DM) and the potential role brepocitinib could play in improving the lives of patients with DM.

Neurocrine Biosciences Appoints Lewis Choi as Chief Information Officer

SAN DIEGO, June 9, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the appointment of Lewis Choi as Chief Information Officer, effective June...

MUSE Microscopy, Inc. Launches Veterinary Digital Pathology with the First-of-Its-Kind Tissue-to-Direct Digital Imaging for the Veterinary Market

IRVINE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc., a pioneer in digital pathology innovation, today announced the formation of MUSE Veterinary Digital Pathology, LLC, a wholly-owned subsidiary focused on transforming pathology through point-of-care service. This initiative aims to provide same-day results for tissue biopsies. This new service will provide the gold standard of patient care allowing veterinarians to deliver pet parents with diagnosis, prognosis, and treatment plans efficiently using the SmartPath MUSE Technology™ (SmartPath)* Platform.

Les Laboratoires nucléaires canadiens et l’Université d’Ottawa accélèrent la recherche sur le rayonnement à faible dose et font progresser la prochaine génération de scientifiques

Un nouveau partenariat renforce le leadership international du Canada dans la recherche sur le rayonnement à faible dose
Un nouveau partenariat renforce le leadership international du Canada dans la recherche sur le rayonnement à faible dose

Canadian Nuclear Laboratories and the University of Ottawa Accelerate Low Dose Radiation Research and Foster Next Generation of Scientists

New partnership furthers Canada’s international leadership in low dose radiation research
New partnership furthers Canada’s international leadership in low dose radiation research

Puratos and AMF Bakery Systems Launch Cutting-Edge Pilot Bakery Plant at Puratos USA Headquarters in Pennsauken, NJ

PENNSAUKEN, N.J., June 9, 2025 /PRNewswire/ -- Puratos, a global leader in innovative bakery, sweet goods, and chocolate ingredients, proudly announces the opening of...

AlidaBio Launches First Service Provider Partnership with Baylor College of Medicine’s GARP Core to Offer Multiplexed RNA Modification Sequencing

SAN DIEGO, June 9, 2025 /PRNewswire/ -- Alida Biosciences, a leader in next-generation RNA modification analysis, is proud to announce its first official service provider:...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTechnologies